Welcome to our dedicated page for PACS Group news (Ticker: PACS), a resource for investors and traders seeking the latest updates and insights on PACS Group stock.
PACS Group, Inc. (NYSE: PACS) is a healthcare holding company focused on post-acute care, with independent subsidiaries that operate a large network of skilled nursing and other post-acute and senior living facilities across multiple U.S. states. The PACS news stream highlights how this platform evolves through acquisitions, financing decisions, regulatory developments, and operational milestones.
News about PACS Group frequently covers portfolio expansion, such as the acquisition of additional skilled nursing facilities in new or existing states, and updates on the total number of facilities and patients served. The company also issues releases on its use of an amended and restated credit facility, amendments and waivers under its credit agreement and master leases, and other capital structure matters that affect its ability to fund acquisitions, capital improvements, and working capital.
Because PACS is a public company in a regulated healthcare sector, its news often intersects with governance and compliance topics. Examples include announcements about restating certain previously issued financial statements, the completion of an independent Audit Committee investigation into third-party allegations, and actions taken to enhance regulatory compliance programs and internal controls. The company has also reported on NYSE listing status updates and extensions related to the timing of SEC filings.
Investors and observers can also find PACS news on leadership changes, such as appointments of compliance and human resources executives or interim finance leaders, as well as earnings releases, preliminary operating metrics, and conference presentations. For readers following PACS stock (PACS), this news feed provides a centralized view of the company’s operational performance, expansion activity, governance developments, and other events disclosed in press releases and related filings.
PACS Group (NYSE: PACS) appointed Dr. Patrick H. Conway to its Board of Directors on March 5, 2026, adding a leader with federal payment-policy, clinical, and health-system executive experience.
PACS operates >320 facilities across 17 states, serves ~31,700 patients daily, and reported 2025 revenue of $5.29 billion (+29.3% YoY).
PACS Group (NYSE:PACS) reported full‑year 2025 revenue of $5.29 billion, up 29.3% year‑over‑year, with net income of $191.5 million and adjusted EBITDA of $505.0 million.
Q4 2025 revenue was $1.36 billion (+12.4%), adjusted EBITDA $142.1 million, cash from operations was $404.2 million, and full‑year 2026 guidance targets $5.65–5.75 billion revenue and $555–575 million adjusted EBITDA.
PACS Group (NYSE:PACS) intends to release its fiscal year and fourth quarter 2025 financial results after market close on February 26, 2026. Management will host a conference call the same day at 5:30 p.m. ET to discuss results and related information.
Investors may join via webcast on the PACS investor website or by dialing the provided phone numbers; a recording will be available for replay for 30 days.
PACS Group (NYSE: PACS) announced the acquisition of operations for three post-acute care facilities—two in the Kenai Peninsula, Alaska, and one in the Boise, Idaho area—adding a combined 230 beds. PACS acquired the real estate for the two Alaska facilities and will lease the Idaho facility from a third-party landlord. The company also acquired the real estate for two existing skilled nursing centers: Sierra Valley Rehab Center (Porterville, CA) and Apache Junction Health Center (near Phoenix, AZ). These moves expand PACS' portfolio to 324 communities in 17 states with nearly 36,000 beds, reflecting the company’s strategy to grow operations and selectively increase real estate ownership.
PACS Group (NYSE:PACS) announced that Jason Murray, Chairman and CEO, and Mark Hancock, Executive VP and Interim CFO, will present at the annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2026 at 5:15 p.m. Pacific Time. The presentation audio will be webcast live via the company’s Investor Relations site at https://ir.pacs.com and an archived recording will be available for at least 30 days after the presentation.
PACS (NYSE:PACS) announced additions to its executive leadership: Kelly Priegnitz as Chief Compliance Officer (effective Dec 1, 2025) and Trent Bingham as Chief Human Resources Officer (joined Nov 10, 2025).
Priegnitz previously served as Executive Vice President and Chief Legal and Compliance Officer at Pinnacle Treatment Centers and held senior compliance roles at Trilogy Health Services, Healogics, and Kindred Healthcare. Bingham’s background includes HR leadership at Swire Coca-Cola, Renalytix, Edwards Lifesciences, eBay, and Eli Lilly; he is a CPA with an MBA from Brigham Young University.
The company said Kathy Lauer will advise through Q1 2026 to support the compliance transition.
PACS (NYSE: PACS) announced an amendment and waiver to its Amended and Restated Credit Agreement and acquired operations plus real estate of a 160-bed skilled nursing facility in Las Vegas, Nevada.
Key financial moves include waiver of defaults from a prior forbearance, a temporary modification to the $100 million unrestricted cash covenant until after reporting the quarter ending June 30, 2026, and current borrowings of $100 million drawn with approximately $500 million available under its $600 million credit facility. The acquisition brings PACS to 321 operations across 17 states.
PACS Group (NYSE: PACS) reported third-quarter 2025 results and completed a restatement and an Audit Committee investigation, and is current with SEC filings as of November 19, 2025. Q3 2025 revenue was $1.34B (+31.0% YoY); net income was $52.3M; Adjusted EBITDA was $131.5M. YTD revenue was $3.93B (+36.4%); YTD adjusted EBITDA was $363.0M. Cash provided by operations was $407.6M for the nine months ended Sept 30, 2025, and cash and equivalents were $355.7M at Sept 30, 2025.
The company completed a restatement that reduced revenue by $14.9M for Q1 2024 and $46.1M for Q2 2024, and the Audit Committee investigation into a short-seller report has concluded. Full-year 2025 guidance: revenue $5.25B–$5.35B; Adjusted EBITDA $480M–$490M.
PACS Group (NYSE:PACS) said it intends to release its third quarter 2025 financial results and file outstanding SEC reports for the period ended September 30, 2025 on Wednesday, November 19, 2025. Management will host an investor call on November 19, 2025 at 5:30 p.m. ET to discuss results. The company filed a Form 12b-25 notifying the SEC of a late Form 10-Q, and expects the 10-Q to be filed within the five-day extension under Rule 12b-25.
Investors can join the live webcast via the PACS investor website or by dialing the provided numbers; a recording will be available for 30 days after the call.
PACS Group (NYSE:PACS) has received an extension from NYSE for continued listing through November 19, 2025, providing additional time to complete financial restatements for Q1 and Q2 2024. The company has expanded significantly, operating 316 healthcare facilities across 17 states, with the addition of 96 facilities since Q2 2024.
The company reports strong operational metrics, including 88.9% total facility occupancy (vs. 78.0% industry average) and $294.2 million in cash and equivalents as of June 30, 2025. Additionally, 64.6% of its skilled nursing portfolio achieved 4 or 5-star CMS QM ratings.
PACS has appointed Mark Hancock as interim CFO, replacing Derick Apt, and has retained a new interim Chief Compliance Officer to enhance regulatory compliance processes.